Who Should Be Screened for Lung Cancer? And Who Gets to Decide?

• Autores: Michael K. Gould
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 315, Nº. 21, 2016, págs. 2279-2281
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Screening for lung cancer has come of age at a time when traditional approaches to mass screening are being challenged.1 For some cancers, physicians are moving slowly from a paternalistic model in which screening is considered mandatory for any patient who belongs to a defined high-risk group, to a newer patient-centered model in which the decision to screen is individualized and informed by a detailed discussion of potential benefits and harms. Conversations about cancer screening increasingly occur in the context of personalized medicine, individualized risk assessment, and shared decision making.